Glanzman Robert 4
4 · Clene Inc. · Filed May 18, 2022
Insider Transaction Report
Form 4
Clene Inc.CLNN
Glanzman Robert
Chief Medical Officer
Transactions
- Sale
Common Stock
2022-05-16$2.03/sh−4,717$9,576→ 10,564 total
Footnotes (1)
- [F1]The sales reported in this Form 4 represent shares of common stock of Clene Inc. required to by sold by Mr. Glanzman to satisfy tax withholding obligations in connection with the vesting of restricted stock awards. The sale occurred automatically to satisfy the tax withholding obligation to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan and does not represent a discretionary transaction by Mr. Glanzman.